HMO adult benefits are transforming our understanding of nutrition beyond infancy. While human milk oligosaccharides have long been celebrated for their role in infant development, groundbreaking research now reveals that these remarkable compounds may support health and wellness throughout our entire lifespan.
For decades, we’ve known that breast milk is the gold standard for infant nutrition. What makes it so special? Beyond proteins and fats, breast milk contains over 200 unique carbohydrates called human milk oligosaccharides (HMOs), which represent the third most abundant component after lactose and lipids. These complex sugars aren’t digested by babies—or adults. Instead, they travel intact to the colon, where they interact with our gut bacteria in fascinating ways. Now, scientists are discovering that the benefits of HMOs extend far beyond the nursery.
What Makes HMOs Special for Adults?
Unlike simple sugars that provide calories, HMOs function as sophisticated biological messengers. They’re prebiotics, meaning they selectively feed beneficial bacteria in our gut. But that’s just the beginning of their story.
Recent studies using advanced gut models have revealed something surprising: HMOs behave differently in adult intestines than they do in infants. While infant gut bacteria (primarily Bifidobacterium species) readily consume HMOs, adult gut microbiomes respond in more diverse ways. Research published in Microorganisms found that specific HMOs called sialyllactose (including both 3′-SL and 6′-SL) don’t necessarily increase Bifidobacterium in adults. Instead, they promote entirely different beneficial bacteria—particularly those that produce short-chain fatty acids like propionate and butyrate.
Why does this matter? Short-chain fatty acids are powerhouse molecules that protect against cardiovascular issues, reduce inflammation, and serve as primary fuel for intestinal cells. This non-bifidogenic effect suggests that HMOs may offer unique health advantages specifically tailored to adult physiology.
Strengthening the Gut Barrier: Your First Line of Defense
One of the most exciting discoveries about HMO adult benefits involves the intestinal barrier—a selective filter that allows nutrients in while keeping harmful substances out. This barrier depends on microscopic proteins called tight junctions that seal the spaces between intestinal cells.
When tight junctions weaken, it can lead to what scientists call increased intestinal permeability. This condition has been linked to chronic inflammation, metabolic disorders, and immune dysregulation. Here’s where HMOs shine: studies demonstrate that sialyllactose significantly improves gut barrier function in adults.
In controlled laboratory models simulating the human digestive system, treatment with both 3′-SL and 6′-SL reduced intestinal permeability and supported the expression of crucial tight junction proteins like ZO-1 and occludin. The culture supernatant from HMO-treated gut bacteria improved barrier integrity when applied to intestinal cell models, suggesting that HMOs work both directly and through their positive effects on gut microbiota.
Modulating the Adult Microbiome for Better Health
Your gut microbiome—the trillions of bacteria living in your intestines—profoundly influences digestion, immunity, and even brain function. As we age, this microbial community often becomes less diverse and less resilient. HMOs may help counteract these changes.
A groundbreaking clinical study published in Scientific Reports administered a complex mixture of HMOs to 32 healthy adults for seven days. The results were remarkable: HMO supplementation induced dose-dependent expansion of beneficial bacteria, altered microbial gene content, and shifted metabolite levels in ways that persisted for weeks after supplementation ended.
Sialyllactose specifically increased populations of Phascolarctobacterium and Lachnospiraceae—bacteria known for producing health-promoting metabolites. These bacteria convert complex carbohydrates into short-chain fatty acids that support metabolic health, regulate immune responses, and maintain intestinal homeostasis.
Supporting Muscle Health Through Metabolic Pathways
Emerging research suggests that HMO adult benefits extend beyond the gut. Studies on 6′-sialyllactose have revealed intriguing effects on muscle metabolism and performance.
Animal research demonstrated that 6′-SL supplementation affected exercise performance by influencing muscle mass, fiber composition, and the expression of myosin heavy chain (MHC) proteins—key markers of muscle function. Mice receiving 6′-SL showed increased expression of slow MHC, which is associated with aerobic metabolism and endurance.
During exercise trials, 6′-SL supplementation was associated with decreased blood lactate levels and reduced blood urea nitrogen (BUN)—a marker of muscle fatigue. These findings suggest that sialyllactose may support energy metabolism in muscle tissue, potentially helping adults maintain strength and reduce exercise-related fatigue.
Human pilot studies in patients with muscle disorders have shown promising results, with improvements in limb muscle power observed following sialyllactose supplementation. While more research is needed, these initial findings open exciting possibilities for supporting muscle health as we age.
Immune Function and Inflammatory Balance
HMOs don’t just feed good bacteria—they also communicate directly with our immune system. Research indicates that HMOs can modulate both innate and adaptive immune responses, helping maintain the delicate balance between fighting infections and avoiding excessive inflammation.
In adult studies, HMO supplementation has been associated with increased levels of anti-inflammatory cytokines like IL-10 and TGFβ, while reducing pro-inflammatory markers. This immunomodulatory effect may be particularly valuable for adults dealing with chronic low-grade inflammation, often called “inflammaging,” which contributes to many age-related health challenges.
The sialylated HMOs (3′-SL and 6′-SL) appear especially potent in this regard. The sialic acid component of these molecules can directly interact with immune cells and help prevent pathogenic bacteria from adhering to intestinal surfaces—a protective mechanism that benefits people of all ages.
The Science of Individual HMOs: Not All Are Created Equal
While breast milk contains over 200 different HMO structures, not all have been studied equally. The most researched HMOs include 2′-fucosyllactose (2′-FL) and lacto-N-neotetraose (LNnT), which have been shown to be well-tolerated in adults and to support beneficial shifts in gut microbiota composition.
However, sialyllactose—particularly 3′-SL and 6′-SL—represents a fascinating frontier. These sialylated HMOs contain sialic acid, a component that’s abundant in neural tissue and plays crucial roles in cell-to-cell communication. The presence of sialic acid gives these HMOs unique biological properties that may complement the effects of neutral HMOs like 2′-FL.
Research suggests that different HMOs may have synergistic effects when consumed together, potentially offering benefits that exceed what any single HMO could provide. This complexity underscores why studying individual HMOs and their specific mechanisms is essential for developing targeted nutritional interventions for adults.
From Breast Milk to Adult Wellness: A Promising Future
The expanding body of research on HMO adult benefits represents a paradigm shift in nutritional science. For years, we assumed that HMOs were exclusively beneficial for infants. Now we understand that these remarkable molecules may support health throughout life by:
- Promoting beneficial changes in adult gut microbiota composition
- Enhancing production of health-promoting metabolites like short-chain fatty acids
- Strengthening intestinal barrier function and tight junction integrity
- Supporting balanced immune responses and reducing chronic inflammation
- Potentially contributing to muscle metabolism and physical performance
As biotechnology advances, specific HMOs like 2′-FL, LNnT, 3′-SL, and 6′-SL can now be produced through precision fermentation, making them accessible for adult nutrition applications. Clinical trials continue to explore optimal dosing, specific health applications, and long-term safety—all of which look promising based on current evidence.
The journey from understanding HMOs as infant nutrition components to recognizing their potential for lifelong health represents one of the most exciting developments in nutritional science. Whether you’re interested in digestive wellness, immune support, or maintaining physical vitality as you age, the emerging science of HMOs offers evidence-based hope for a healthier future.
That’s why Siallac® was developed—to bring the benefits of scientifically-validated HMOs like 6′-SL and 3′-SL to adults seeking to support their muscle health and gut wellness as they age.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
References
- Sato, Y., Kanayama, M., Nakajima, S., Hishida, Y., & Watanabe, Y. (2024). Sialyllactose Enhances the Short-Chain Fatty Acid Production and Barrier Function of Gut Epithelial Cells via Nonbifidogenic Modification of the Fecal Microbiome in Human Adults. Microorganisms, 12(2), 252. https://doi.org/10.3390/microorganisms12020252
- Šuligoj, T., Vigsnæs, L. K., Abbeele, P. V., Apostolou, A., Karalis, K., Savva, G. M., McConnell, B., & Juge, N. (2020). Effects of Human Milk Oligosaccharides on the Adult Gut Microbiota and Barrier Function. Nutrients, 12(9), 2808. https://pmc.ncbi.nlm.nih.gov/articles/PMC7551690/
- Bajic, D., Wiens, F., Wintergerst, E., Deyaert, S., Baudot, A., & Van den Abbeele, P. (2023). HMOs Exert Marked Bifidogenic Effects on Children’s Gut Microbiota Ex Vivo, Due to Age-Related Bifidobacterium Species Composition. Nutrients, 15(7), 1701. https://www.nature.com/articles/s41598-023-41040-5
- Lee, S. Y., Park, S. J., Seo, S. H., Yoo, Y., & Sung, J. S. (2024). 6′-Sialyllactose Improves Physical Performance by Increasing Muscle Mass and Strength and by Reducing Fatigue. Nutrients, 16(16), 2600. https://doi.org/10.3390/nu16162600
- Kong, C., Faas, M. M., de Vos, P., & Akkerman, R. (2021). Impact of dietary fibers in infant formulas on gut microbiota and the intestinal immune barrier. Food & Function, 12(22), 9855-9869.
- Elison, E., Vigsnaes, L. K., Rindom Krogsgaard, L., Rasmussen, J., Sørensen, N., McConnell, B., Hennet, T., Sommer, M. O., & Bytzer, P. (2016). Oral supplementation of healthy adults with 2′-O-fucosyllactose and lacto-N-neotetraose is well tolerated and shifts the intestinal microbiota. British Journal of Nutrition, 116(8), 1356-1368. https://pubmed.ncbi.nlm.nih.gov/27719686/
- Perdijk, O., van Baarlen, P., Fernandez-Gutierrez, M. M., van den Brink, E., Schuren, F. H., Brugman, S., Savelkoul, H. F., Kleerebezem, M., & van Neerven, R. J. (2019). Sialyllactose and Galactooligosaccharides Promote Epithelial Barrier Functioning and Distinctly Modulate Microbiota Composition. Frontiers in Immunology, 10, 94. https://www.mdpi.com/1422-0067/22/13/6729
- Turner, J. R. (2023). Paracellular permeability and tight junction regulation in gut health and disease. Nature Reviews Gastroenterology & Hepatology, 20, 417-432. https://www.nature.com/articles/s41575-023-00766-3
- Soyyılmaz, B., Mikš, M. H., Röhrig, C. H., Matwiejuk, M., Meszaros-Matwiejuk, A., & Vigsnæs, L. K. (2021). The Mean of Milk: A Review of Human Milk Oligosaccharide Concentrations throughout Lactation. Nutrients, 13(8), 2737.
- Walsh, C., Lane, J. A., van Sinderen, D., & Hickey, R. M. (2020). Human milk oligosaccharides: Shaping the infant gut microbiota and supporting health. Journal of Functional Foods, 72, 104074.
